Kent Imaging Receives MedTech Innovation Award

Kent Imaging is pleased to announce that they have been selected as Most Innovative Medical Imaging Technology Developer - Canada, for 2023, from Corporate America.

Kent’s flagship product, SnapshotNIR, is a Canadian-made near-infrared (NIR), reflectance-based technology that measures tissue oxygen saturation (StO2) in superficial tissue. Using multiple wavelengths of NIR light, SnapshotNIR measures relative amounts of oxygenated and deoxygenated hemoglobin in the microcirculation where oxygen exchange is happening. Snapshot provides users with a tissue oxygenation map that can be used in medical decision-making for tracking and trending oxygenation and evaluating tissue viability in wound care. SnapshotNIR is a portable and handheld medical device that uses near-infrared spectroscopy to image tissue oxygenation at the microvascular level.

The cost-effective and easy-to-use wound imaging device is completely non-invasive, eliminating the need for patient contact or injected dyes. It allows clinicians to accurately capture diagnostic insight into the availability of oxygenated blood in tissue. SnapshotNIR’s actionable data is helping to provide insight for improved decision-making, forging a path in advanced diagnostic-driven wound care throughout the continuum of care.

At Kent, our mission is to improve outcomes and reduce complications in as many patients as possible. It is an honor to be recognized for our dedication to MedTech innovations.